Bio/Pharma News

Jan 29, 2013
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
Ben Venue Laboratories announced that it has voluntarily entered into a consent decree with FDA over violations of cGMP.
Jan 28, 2013
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
GlaxoSmithKline has formed a joint venture with Indian vaccines company Biological E to research and develop a six-in-one combination pediatric vaccine to help protect children in India and other developing countries from certain infectious diseases.
Jan 25, 2013
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
Following its recent acquisition, Actavis (formerly Watson Pharmaceuticals) unveiled its long-term growth strategy during its investor meeting in New York.
Jan 25, 2013
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
AstraZeneca and Ceram Research, a materials development company based in the UK, have signed an agreement whereby Ceram will develop its inorganic-based controlled release technology in a feasibility study for delivering select AstraZeneca compounds.
Jan 24, 2013
ePT--the Electronic Newsletter of Pharmaceutical Technology
Allergan and MAP Pharmaceuticals have entered into a definite merger agreement under which Allergan will purchase all of MAP?s outstanding shares for the price of $25.00 per share.
Jan 16, 2013
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
FDA has issued a Warning Letter to Hameln Pharmaceuticals GmbH after observing "significant" cGMP violations for finished pharmaceuticals at the company?s facility in Hameln, Germany.
Jan 09, 2013
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
A roundup of developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.
Jan 08, 2013
ePT--the Electronic Newsletter of Pharmaceutical Technology
Eli Lilly expects overall revenue growth in the coming year.
Jan 07, 2013
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
AbbVie, a research-focused, specialty biopharmaceutical company that was spun off from Abbott Pharmaceuticals, was officially launched on Jan. 2, 2013
Dec 27, 2012
ePT--the Electronic Newsletter of Pharmaceutical Technology
By Pharmaceutical Technology Editors
Amgen has agreed to pay $762 million to resolve criminal liability and false claims act allegations.
native1_300x100
lorem ipsum